GLP-1INSURANCE AND ACCESS
Indian pharmaceutical companies are launching cheaper generic versions of GLP-1 drugs, creating a price war against Novo Nordisk’s branded medications like Ozempic and Wegovy. This competition could make these weight-loss treatments more affordable globally.